Diversity of phenotype was observed between patients with BRAF and MAP2K1/2 variants, and automated facial image analysis tools (Face2Gene) failed to distinguish CFC patients by genotype. This evidence concerns the gene BRAF and cardiofaciocutaneous syndrome.